SCHEMBL3834826

SCHEMBL3834826

O=C(O)C(Nc1ccc(-n2ccc3ccccc3c2=O)cc1)c1ccc(Cl)s1

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 18/20 0.34
▸ GAA P10253 1/20 0.32
▸ F2 P00734 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1639115 0.86 F10 (0.42) F10F2
SCHEMBL3835105 0.85 ROCK2 (0.36) F10F2
SCHEMBL3834640 0.84 MIF (0.33) F2
SCHEMBL3836616 0.84 MEN1 (0.34) F10
SCHEMBL3839792 0.84 EGFR (0.34) F10GAA
SCHEMBL3834891 0.83 GAA (0.38) F10GAA
SCHEMBL3837178 0.81 P2RY12 (0.40) F10
SCHEMBL3842545 0.81 LMNA (0.38) GAA
SCHEMBL3837759 0.76 TP53 (0.47) GAA
SCHEMBL14273367 0.73 F10 (0.36) F10F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2094272-A2 NITROGEN CONTAINING SUBSTITUTED HETEROCYCLES AS PLATELET ADP RECEPTOR INHIBITORS Portola Pharmaceuticals, Inc. (US) 2009-09-02 — — EP claimed
WO-2008036843-A2 NITROGEN CONTAINING SUBSTITUTED HETEROCYCLES AS PLATELET ADP RECEPTOR INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2008-03-27 — — WO claimed
EP-2094272-A2 NITROGEN CONTAINING SUBSTITUTED HETEROCYCLES AS PLATELET ADP RECEPTOR INHIBITORS Portola Pharmaceuticals, Inc. (US) 2009-09-02 — — EP disclosed
WO-2008036843-A2 NITROGEN CONTAINING SUBSTITUTED HETEROCYCLES AS PLATELET ADP RECEPTOR INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2008-03-27 — — WO disclosed
Send feedback